Recent Articles from Benzinga

Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.

GameStop Stock Sees Increased Activity: What's Going On?benzinga.com
Via Benzinga · January 27, 2026
What's Going On With TeraWulf Stock Tuesday?benzinga.com
TeraWulf Inc. stock rises on positive market sentiment, with a 8.34% increase in regular trading hours; potential uptrend continuation.
Via Benzinga · January 27, 2026
Elon Musk Says SpaceX Exists To 'Make Star Trek Real'—Wants Epic Futuristic Spaceships With 'Lots Of People' To Travel Star Systems And Meet Aliensbenzinga.com
Via Benzinga · January 27, 2026
Why Is IONQ Stock Trading Higher Today?benzinga.com
IonQ Inc. (IONQ) shares are trading higher in Tuesday's pre-market session as the company expands its quantum technology control with the acquisition of U.S. chip manufacturer SkyWater Technology Inc. (SKYT) in a deal valued at roughly $1.8 billion, SkyWater said Monday.
Via Benzinga · January 27, 2026
CoreWeave Stock Soars Following Expanded Nvidia Collaborationbenzinga.com
CoreWeave Inc (NASDAQ:CRWV) is trading higher on Tuesday after Deutsche Bank upgraded the stock from Hold to Buy and lifted its price target from $100 to $140.
Via Benzinga · January 27, 2026
Under the Radar: How to Find Growth Before Wall Street Shows Upbenzinga.com
Via Benzinga · January 27, 2026
Insights into National Fuel Gas's Upcoming Earningsbenzinga.com
Via Benzinga · January 27, 2026
A Glimpse of Levi Strauss's Earnings Potentialbenzinga.com
Via Benzinga · January 27, 2026
Why Is Pfizer Stock Rising Tuesday?benzinga.com
Pfizer Inc. (PFE) shares are trading higher on Tuesday, as the stock benefits from a price target increase at Cantor Fitzgerald. The firm raised its target to $27 from $24, providing a catalyst for the pharmaceutical giant even as the broader Healthcare sector declined 1.6% during the session.
Via Benzinga · January 27, 2026
What's Going On With Maplebear Stock Tuesday?benzinga.com
Maplebear Inc. stock falls as Amazon expands grocery delivery, despite Instacart's new partnerships with retail tech and loyalty strategy.
Via Benzinga · January 27, 2026
BiomX (PHGE) Stock Surges: A Single Buyer Now Owns Nearly 20%benzinga.com
Biomx shares are surging Tuesday afternoon following a 13D filing that disclosed Pyu Pyu Capital's acquisition of a 19.99% stake in the company.
Via Benzinga · January 27, 2026
Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drugbenzinga.com
Aclaris Therapeutics reported early study results showing its ATI-2138 drug drove rapid and lasting hair regrowth, outperforming Pfizer's Litfulo in a severe hair loss mouse model.
Via Benzinga · January 27, 2026
What's Going On With Affirm Holdings Stock On Tuesday?benzinga.com
Affirm shares initially traded higher on a new Bolt BNPL partnership and analyst upgrade, though the stock later trimmed its gains.
Via Benzinga · January 27, 2026
Insights Ahead: Hexcel's Quarterly Earningsbenzinga.com
Via Benzinga · January 27, 2026
A Preview Of LG Display Co's Earningsbenzinga.com
Via Benzinga · January 27, 2026
A Look Ahead: Meritage Homes's Earnings Forecastbenzinga.com
Via Benzinga · January 27, 2026
Intellia Moves Forward As FDA Removes Trial Hold For Rare Disorderbenzinga.com
FDA removes the clinical hold on Intellia's Phase 3 trial for a rare nerve disease after safety updates, while review continues for its heart disease program.
Via Benzinga · January 27, 2026
Examining the Future: Littelfuse's Earnings Outlookbenzinga.com
Via Benzinga · January 27, 2026
An Overview of Plexus's Earningsbenzinga.com
Via Benzinga · January 27, 2026
Uncovering Potential: Prosperity Bancshares's Earnings Previewbenzinga.com
Via Benzinga · January 27, 2026
Texas Instruments Likely To Report Higher Q4 Revenue; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Callbenzinga.com
Via Benzinga · January 27, 2026
What's Next: LendingClub's Earnings Previewbenzinga.com
Via Benzinga · January 27, 2026
A Look Ahead: Hawkins's Earnings Forecastbenzinga.com
Via Benzinga · January 27, 2026
Beyond The Numbers: 4 Analysts Discuss Beta Bionics Stockbenzinga.com
Via Benzinga · January 27, 2026
Insights into Avnet's Upcoming Earningsbenzinga.com
Via Benzinga · January 27, 2026
Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complicationbenzinga.com
Mesoblast reports early real-world data showing 84% survival in children treated with FDA-approved Ryoncil, as the company expands hospital access and prepares an adult trial.
Via Benzinga · January 27, 2026
Spotlight on Meta Platforms: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · January 27, 2026
This Is What Whales Are Betting On First Majestic Silverbenzinga.com
Via Benzinga · January 27, 2026
What Analysts Are Saying About Valvoline Stockbenzinga.com
Via Benzinga · January 27, 2026
Looking At Visa's Recent Unusual Options Activitybenzinga.com
Via Benzinga · January 27, 2026
6 Analysts Assess Syndax Pharmaceuticals: What You Need To Knowbenzinga.com
Via Benzinga · January 27, 2026
Is Texas Instruments Inc Gaining or Losing Market Support?benzinga.com
Via Benzinga · January 27, 2026
Price Over Earnings Overview: KeyCorpbenzinga.com
Via Benzinga · January 27, 2026
Peering Into Galaxy Payroll Group Ltd's Recent Short Interestbenzinga.com
Via Benzinga · January 27, 2026
Peering Into Arrive AI Inc's Recent Short Interestbenzinga.com
Via Benzinga · January 27, 2026
Demystifying US Foods Holdings: Insights From 4 Analyst Reviewsbenzinga.com
Via Benzinga · January 27, 2026
Assessing SkyWater Technology: Insights From 5 Financial Analystsbenzinga.com
Via Benzinga · January 27, 2026
Crude Oil Rises 2%; Boeing Shares Fall After Q4 Resultsbenzinga.com
Via Benzinga · January 27, 2026
What 13 Analyst Ratings Have To Say About Merck & Cobenzinga.com
Via Benzinga · January 27, 2026
S&P 500 Hits New Records, GM Stock Jumps 8% On Earnings: What's Moving Markets Tuesday?benzinga.com
Wall Street regained momentum on Tuesday as upbeat corporate earnings lifted risk appetite, pushing the S&P 500 to fresh all-time highs and driving the Nasdaq 100 closer to its prior October record.
Via Benzinga · January 27, 2026
5 Materials Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · January 27, 2026
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · January 27, 2026
12 Industrials Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · January 27, 2026
Kazia Therapeutics Reports Positive Early Responses In Aggressive Breast Cancer Trialbenzinga.com
Kazia Therapeutics shared clinical update on Phase 1b study of paxalisib for late-stage metastatic TNBC. Encouraging responses observed.
Via Benzinga · January 27, 2026
Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investmentsbenzinga.com
Genenta plans a major shift into defense businesses, backing weapons maker ATC, rebranding as Saentra Forge and reshaping its future as shares see sharp moves.
Via Benzinga · January 27, 2026
Buffett Bet Big On UnitedHealth Stock In Q2 — Now Berkshire Hathaway Could Be Down Billionsbenzinga.com
Warren Buffett unveiled a purchase in UNH stock in 2025. The position could be costing Berkshire Hathaway in 2026.
Via Benzinga · January 27, 2026
What's Going On With Northrup Grumman Stock?benzinga.com
Shares of Northrop Grumman Corporation (NASDAQ: NOC) are up Tuesday after the defense company reported quarterly earnings that showed a backlog of $95.7 billion for next-generation defense systems.
Via Benzinga · January 27, 2026
CGI Teams Up With OpenAI To Scale Enterprise AIbenzinga.com
CGI announced a global go-to-market alliance with OpenAI to help regulated enterprises deploy AI securely at scale.
Via Benzinga · January 27, 2026
Earnings Outlook For First Interstate BancSysbenzinga.com
Via Benzinga · January 27, 2026
What's Next: First Financial Bancor's Earnings Previewbenzinga.com
Via Benzinga · January 27, 2026
A Peek at New Oriental Education's Future Earningsbenzinga.com
Via Benzinga · January 27, 2026
5 Communication Services Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · January 27, 2026
10 Information Technology Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · January 27, 2026
The Real Reason Why Bitcoin's Never-Ending Range Just Doesn't Breakbenzinga.com
Bitcoin (CRYPTO: BTC) has remained locked in a tight range for nearly 60 days, with selling pressure preventing a sustained move higher.
Via Benzinga · January 27, 2026
Another Government Shutdown Looms: These 10 Stocks Suffered Last Timebenzinga.com
U.S. shutdown risk rises as DHS funding talks stall ahead of Jan. 30 deadline. Polymarket odds jump to 79% as markets recall uneven sector moves last time.
Via Benzinga · January 27, 2026
Elizabeth Warren Says Private Equity 'Guts Everything' From Toys R Us, Kmart To Hospitals And Prisons —Then Walks Away 'Pockets Stuffed With Cash'benzinga.com
Via Benzinga · January 27, 2026
A Look at Tetra Tech's Upcoming Earnings Reportbenzinga.com
Via Benzinga · January 27, 2026
Earnings Outlook For Adtalem Glb Educationbenzinga.com
Via Benzinga · January 27, 2026
What's Next: Calix's Earnings Previewbenzinga.com
Via Benzinga · January 27, 2026
A Peek at Las Vegas Sands's Future Earningsbenzinga.com
Via Benzinga · January 27, 2026
Ryan Cohen Is The Next Warren Buffett? Michael Burry Thinks Sobenzinga.com
Michael Burry sees GameStop as more than a struggling retailer— he sees a $4 billion war chest led by visionary Ryan Cohen.
Via Benzinga · January 27, 2026
Oscar Health (OSCR) Slides As Medicare Proposal, UnitedHealth Miss Rock Insurer Stocksbenzinga.com
Oscar Health Inc (NYSE: OSCR) shares are trading lower Tuesday morning as investors react to a surprise Medicare Advantage update from the Trump administration.
Via Benzinga · January 27, 2026
Railroad Operator Union Pacific Operating Ratio Worsens In Q4benzinga.com
Union Pacific Corporation (NYSE: UNP) reports Q4 2025 financial results with $1.8B net income, missing analyst estimates. Operational efficiency improved.
Via Benzinga · January 27, 2026
Broadcom Set To Dominate Custom AI Chip Market With 60% Share By 2027, Counterpoint Saysbroadcom
Counterpoint Research says big tech companies like Alphabet (Google), Amazon, Microsoft and Apple are rapidly expanding custom AI chips to power data centers, with shipments expected to triple by 2027 as demand for faster, more efficient AI grows.
Via Benzinga · January 27, 2026
Redwire (RDW) Stock Soars On Missile Defense Agency Contract Awardbenzinga.com
Redwire Corporation (NYSE: RDW) shares are trading higher Tuesday after the company announced it secured a Missile Defense Agency contract.
Via Benzinga · January 27, 2026
What's Next: Textron's Earnings Previewbenzinga.com
Via Benzinga · January 27, 2026
A Preview Of Stifel Financial's Earningsbenzinga.com
Via Benzinga · January 27, 2026
Wall Street Turns Cautious After Trade Desk CFO Exitbenzinga.com
Trade Desk Inc. (TTD) stock fell after CFO termination. Analysts cite concerns over leadership and reduced price forecast.
Via Benzinga · January 27, 2026
AI Software Company Secures $50 Million From Maven, YFM Equitybenzinga.com
YFM Equity Partners, Maven Capital and several other firms have invested $50 million into AI software company Summize.
Via Benzinga · January 27, 2026
From Tokyo To Oslo, Country ETFs Are Running Hot As Global Markets Ride Policy Shifts, AI Buzzbenzinga.com
From Norway to Japan, here are a few country ETFs that are trading near their 52-week highs driven by policy shifts, tech trends and macro tailwinds.
Via Benzinga · January 27, 2026
12 Communication Services Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · January 27, 2026
12 Information Technology Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · January 27, 2026
Is Nvidia Investing In CoreWeave, Or Its Own Next Quarter?benzinga.com
Nvidia's $2B investment in CoreWeave is a vote of confidence in AI infrastructure, but skeptics believe it creates synthetic demand...
Via Benzinga · January 27, 2026
Examining the Future: MSCI's Earnings Outlookbenzinga.com
Via Benzinga · January 27, 2026
An Overview of Raymond James Finl's Earningsbenzinga.com
Via Benzinga · January 27, 2026